Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.
New research in The American Journal of Pathology identifies the protein-linked receptor C5aR1 as a novel prognostic biomarker and potential therapeutic target to help patients with cutaneous squamous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback